The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for March 18, 2022
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA

Brakke Consulting News
2022 Pain Management Products report – pre-order now
Brakke Recruiting – open position for Head of Swine Segment

Other News 
Best Friends Pet Hotel
Clearlake Capital Group
Dot Family Holdings
Pacific GeneTech
Pet Acoustics
Pet Food Experts
Vimian Group
Wellness Pet Company

Brakke Consulting


Pain management is one of the leading topics in veterinary medicine today. Brakke Consulting’s annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
– estimates of US sales and prices of leading products
– new and upcoming pain management products, including ZORBIUM and monoclonal antibody products LIBRELA and SOLENSIA
– discussion of the use of cannabinoids in veterinary pain management
– 2022 survey of 359 small animal veterinarians regarding use of pain management products

NEW THIS YEAR! The report will feature trended, aggregated practice-level data provided by VetSuccess, including chronic vs. acute use of analgesics, comparisons of analgesic revenue per patient by brand, and data on brand-switching at the patient level.   Pain Management Products for Dogs and Cats 2022 can be purchased for $8,750 if ordered by April 15, 2022, and $9,495 thereafter. The report will be completed in late April. Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at
Brakke Consulting
Opportunity in China for Head of Swine Segment

 BI China seeks a Head of Swine Segment in its Shanghai office. The position is responsible for overall management of the high-profile swine business there. Reporting to the Head are marketing, sales, technical services, and administration. The primary goal is to build and lead an efficient team, achieving short- and long-term goals and commit aggressively to strategic development in China, working with Country and Corporate leadership. 10-15 years’ experience required, MBA preferred. Proficiency in English required, as is demonstrated success working in a foreign country and culture.

Click here for details or to apply.


  • Bimeda I announced the launch of KetoMed, the first FDA-approved generic ketoprofen injection, for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. (company press release)
  • Neogen announced the addition of a new ready-to-use formulation of its Synergize disinfectant for livestock producers. Synergize is a combination quaternary ammonium and glutaraldehyde multi-purpose disinfectant. (IHS Markit Connect)
  • Akorn announced it has sold its seven branded ophthalmic products to Irish pharmaceutical company Théa Pharma in order to focus on growth in areas such as its animal care and human generics businesses. (IHS Markit Connect)
  • Walmart announced it is expanding its pet services in select stores. The retailer has partnered with Best Friends Pet Hotel to offer dog day care services in 10 Walmart locations in Arkansas, Florida, Georgia, North Carolina and Texas. (Pet Product News)
  • Pet Food Experts announced an investment from Dot Family Holdings, the investment office of the Tracy Family, owners and operators of Dot Foods, Inc. Terms were not disclosed. (Pet Business)
  • Bloomberg news has reported that Wellness Pet Company, currently backed by private equity firm Clearlake Capital Group, is preparing to go public in the US as soon as this year, seeking more than $600 million in the initial public offering. (Pet Business)
  • Pet Acoustics announced the launch of an at-home hearing test for companion animals. The Pet Acoustics Home Pet Hearing Test works from any internet-connected device and is designed to assess how well a dog or cat can hear in just one minute, indicating if pets have full hearing, partial hearing or hearing loss. (IHS Markit Connect)
  • Pacific GeneTech (PGT) announced it will move to new US headquarters in Northwest Arkansas, which will allow the company to work more closely with collaborators such as the University of Arkansas, where its adjuvant vaccine platform was derived. PGT’s US presence was previously centered in Louisburg, Kansas. (IHS Markit Connect)
  • UK Vimian Group AB announced it has acquired Avacta Group’s Animal Health Division for an upfront payment of GBP 0.9 million ($1.2 million) and will receive additional deferred consideration of up to GBP 1.4 million ($1.8 million) dependent on the combined performance of the consolidated business. The Animal Health Division had an operating loss of GBP (0.3 million) in 2020. Avacta Animal Health provides veterinary allergy diagnostic solutions through its UK laboratory and re-sells immunotherapy products from Nextmune, a Vimian Group company. (
  • UK TheraVet announced the commercial launch in the UK and Ireland of Biocera-Vet, its new generation bone substitute for bone surgery and for osteosarcoma. (Businesswire)
  • SWEDEN Emollivet, an animal health company developing skin care products for animals, announced it is raising capital via a new share issue to existing owners amounting to SEK 5 million ($500,000). Earlier this month Emollivet launched its first product – Emollivet COMBI, an antiseptic emollient spray for horses with pastern dermatitis. (PRnewswire)



  • US – AVIAN INFLUENZA The Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP) has announced a confirmed case of highly pathogenic avian influenza (HPAI) in a commercial layer flock of 3 million birds. This is Wisconsin’s first confirmed case of HPAI since 2015 and the largest US commercial case reported so far in 2022. (Feedstuffs)
  • US – VETERINARY SCHOOLS Utah lawmakers have approved $18 million in annual funding to Utah State University for a four-year veterinary college. Utah State is currently part of a regional program in which veterinary students complete two years of foundational study at the school and do their final two years at Washington State University’s College of Veterinary Medicine. The new program will be Utah’s first four-year veterinary education program. (AVMA SmartBrief)
  • US – RESEARCH FUNDING The USDA’s National Institute of Food and Agriculture (NIFA) announced an investment of over $13 million in research that explores novel therapies and prevention strategies for animal diseases that cost the agricultural industry billions worldwide. The 24 grants – investigating diseases affecting a full range of species, from cattle, poultry and pigs to horses, sheep and fish – are part of NIFA’s Agriculture and Food Research Initiative’s (AFRI) Diseases of Agricultural Animals program area priority. (Drovers)

This week the state of Wisconsin announced a confirmed case of highly pathogenic avian influenza (HPAI) in a large commercial layer flock, marking the 17th state with a confirmed case in 2022 and the largest commercial case in the country to date.  This serves as a reminder that the spread of diseases, even those that have been around for a number of years, can have significant financial impacts on the animal health industry.  Control measures for HPAI include depopulating the entire premises where the disease is confirmed – in this most recent case, a facility with 3 million birds.

It’s encouraging to note that the USDA is investing in research into preventing these kinds of devastating animal diseases, but $13 million is a drop in the bucket.  Our industry needs to continue to invest in R&D efforts – not just vaccines, but other novel strategies for disease prevention and control – to stay ahead of these wily microbes.

Lynn Fondon


Last week we asked whether you, and your companies, would be returning to in-person attendance at conferences.  80% of you said you would be attending in-person in 2022; 77% said your companies will be exhibiting live at the shows.  Looks like our industry is finally getting back to pre-pandemic activity.

This week
What percentage of your company’s animal health revenue does the R&D budget represent?

en_USEnglish (United States)